Brexit

The European Medicines Verification System Launches to…

The 9th February 2019 marked the launch of the European Medicines Verification System (EMVS) which will use cutting-edge technology to safeguard the medicine supply chain against fake products. Each European country…

Brexit: Much ado about nothing?

Brexit, Brexit, Brexit. It’s all anyone can talk about and yet nobody can tell you with certainty what to expect.…

NHS England’s Long-Term Plan to be Funded by £20.5 Billion

Today NHS England have released their long-term plan to ensure the future of the NHS and the continued care of UK…

Pfizer’s Nordkamp Takes ABPI Presidency

Erik Nordkamp, managing director of Pfizer UK, has been confirmed as the new president of the Association of the…

In Conversation

Only 14 months in position, UK country president at Novartis, Haseeb Ahmad, shares insights into the company’s new strategy. He further analyses how Brexit can be a catalysing force for the UK to lead in life sciences and explains why the country has potential as a test bed for medicine launches. Much has changed at Novartis within the…

Brexit Facts & Figures Snapshot

There is much debate surrounding the potential impact on the UK’s life sciences industry of the…

Cannabinoid Drugs, Medicinal Cannabis & Opioid Drugs: Greece

Cannabinoid Drugs, Medicinal Cannabis & Opioid Drugs in Greece – the complete legal lowdown. Prepared in…

Brexit and Irish Pharma

The UK’s decision to leave the EU in Summer 2016 sent shockwaves throughout Europe and left neighbouring…

Brexit: A Window of Opportunity for France’s Drug Regulator?

As the UK prepares to leave the European Union in March 2019, stakeholders across the European life sciences…

NEW Special Report on UK

Despite a myriad of uncertainties around its decision to leave the European Union, the UK still stands as one of…

Brexit Bites: EMA cuts off Britain

The European Medicines Agency has cut Britain out of its contracts 7 months ahead of Brexit. “You might have been…

Roche boss: Brexit will make the UK less competitive

Last week, Roche Boss Severin Schwan expressed concern that Brexit could further slow the UK drug approval process.…

Brexit: A Serious Threat to Patients

As the UK extracts itself from the European Union, key figures from the country’s life sciences sector are…